Browse articles from EyeWorld.org related to MIGS. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Finding the most effective way to approach a patient with glaucoma can be a challenge, and it may take time to find the best treatment or combination of treatments. Three physicians discussed how they are combining medications with procedural intervention and the future of treatments in the glaucoma field.
In Dr. Provencher’s cyclopexy technique, a long-curved CTC needle with 10-0 Prolene is passed directly through sclera to reappose the ciliary body in the area of the cleft (demarcated by violet marking pen).
Source: Lorraine Provencher, MD
In a fast-paced session at the 2026 ASCRS Annual Meeting, presenters shared videos and pearls on a variety of glaucoma topics, competing for audience votes in this Survivor-themed symposium. Audience members voted off one speaker per round until there was one remaining survivor on “Temporal Island.” Read the recap here.
➤ AMA classifies myopia as a disease
➤ Report marks shift in refractive surgery trends
➤ Patient dosing begins in Phase 2 trial for oral DME therapy
➤ ASCRS news and events
➤ EyeWorld article of the week
Two surgeons discussed benefits to expanding access to the suprachoroidal space, which patients might benefit the most, and other important considerations.
Surgeons who routinely perform cataract surgery could better help patients by learning basic glaucoma procedures and incorporating them into cataract surgery, according to two glaucoma surgeons who spoke to EyeWorld. They discussed how cataract surgeons can gain experience with glaucoma procedures and when it makes sense to incorporate them.
➤ Accommodating lens implanted in first patient
➤ First patient dosed in Phase 2 trial investigating treatment for normal tension glaucoma
➤ Primary endpoint met in Phase 3 trial for glaucoma drop
➤ CE mark approvals
➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy for Stargardt disease
➤ ASCRS news and events
An emphasis on sustainability in healthcare has gained momentum in recent years. In this article, a group of glaucoma specialists who are experts in sustainability offered their perspectives on how to make meaningful changes in a clinical practice.
➤ ASCRS EyeWorld Weekly: View the current issue
➤ Study: COVID-19 significantly reduced rate of ophthalmic procedures
➤ New device provides non-surgical treatment for lower lid laxity
➤ Autonomous Diabetic Retinopathy Screening offers ‘unparalleled results’
➤ 52-week data from Phase 2b study evaluating wet AMD therapy
➤ Subgroup analysis provides additional data on wet AMD therapy
➤ ASCRS news and events
In his introduction to the “Interventional glaucoma” bonus issue of EyeWorld, Chief Medical Editor Sumit “Sam” Garg, MD, shared some of his personal experiences in this space and what topics readers can expect to learn more about.
Glaucoma Editor Manjool Shah, MD, provided his thoughts on the evolution of interventional glaucoma.
